Yuichiro Ii Selected Research

2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropane

1/2020

Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichiro Ii Research Topics

Disease

3	Myasthenia Gravis 06/2020 - 01/2013
3	Neoplasms (Cancer) 06/2020 - 01/2009
2	Atrial Fibrillation 01/2022 - 01/2021
2	Dementia (Dementias) 01/2021 - 01/2017
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2017
2	Parkinsonian Disorders (Parkinsonism) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 03/2015
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
2	Thymoma (Thymic Carcinoma) 10/2017 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 03/2015
2	Thrombophilia 04/2014 - 03/2012
1	Cerebellar Ataxia (Dysmetria) 12/2021
1	Disease Progression 12/2021
1	Intracranial Embolism 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Siderosis 01/2021
1	Proteinuria 06/2020
1	Diplopia (Double Vision) 06/2020
1	Virus Diseases (Viral Diseases) 06/2020
1	Multiple Myeloma 06/2020
1	Prodromal Symptoms 01/2020
1	Necrosis 01/2020
1	Arteriolosclerosis 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2019
1	Embolism (Embolus) 01/2019
1	Cognitive Dysfunction 01/2018
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2017
1	Vasculitis (Vasculitides) 03/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2014
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2012
1	Thrombosis (Thrombus) 01/2012
1	Meningitis 03/2009
1	Encephalitis (Encephalitis, Rasmussen) 01/2009
1	Ovarian Teratoma 01/2009
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2007
1	Hashimoto's encephalitis 10/2007
1	Hashimoto Disease (Thyroiditis, Hashimoto) 10/2007
1	Hypothyroidism 10/2007
1	Leukocytosis (Pleocytosis) 10/2007

Drug/Important Bio-Agent (IBA)

4	AutoantibodiesIBA 12/2021 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2017
3	AntibodiesIBA 06/2020 - 10/2007
3	Protein SIBA 04/2014 - 01/2012
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Cholinergic ReceptorsIBA 06/2020 - 10/2017
2	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 06/2020 - 01/2013
2	Amyloid beta-PeptidesIBA 01/2020 - 03/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 03/2015
2	Protein CIBA 04/2014 - 03/2012
2	AntithrombinsIBA 04/2014 - 03/2012
1	PeroxiredoxinsIBA 01/2021
1	neuromelaninIBA 01/2021
1	IronIBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2020
1	Thalidomide (Thalomid)FDA Link 06/2020
1	Bortezomib (Velcade)FDA Link 06/2020
1	muskIBA 06/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2020
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2020
1	PyrinIBA 05/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 10/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 03/2015
1	Prednisolone (Predate)FDA LinkGeneric 01/2013
1	protein S TokushimaIBA 01/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 10/2007
1	NR2B NMDA receptorIBA 10/2007
1	Methylprednisolone FDA LinkGeneric 10/2007
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	Ionotropic Glutamate ReceptorsIBA 10/2007
1	Thyroglobulin FDA Link 10/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 03/2015
1	Immunotherapy 12/2021
1	Catheter Ablation 01/2021
1	Drug Therapy (Chemotherapy) 06/2020
1	Activities of Daily Living (ADL) 01/2018